Stockscreener 앱 받기
17.00
0.65%
0.11
Neurogene Inc 주식(NGNE)의 최신 뉴스
Aug Catalysts: Is Neurogene Inc a potential multi bagger2025 Trading Volume Trends & AI Based Trade Execution Alerts - baoquankhu1.vn
Rare disease biotech Neurogene to field questions at 3 investor events - Stock Titan
Neurogene announces inducement grant under Nasdaq Listing Rule - marketscreener.com
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
One new Neurogene hire gets 2,820 stock options over 4 years - stocktitan.net
Aug Fed Impact: Is Walgreens Boots Alliance Inc forming a breakout patternJuly 2025 Drop Watch & Consistent Profit Trading Strategies - baoquankhu1.vn
Jobs Data: Does Neurogene Inc have a competitive edgeWeekly Gains Report & Expert-Curated Trade Recommendations - baoquankhu1.vn
Brokers Issue Forecasts for Neurogene FY2025 Earnings - MarketBeat
Neurogene (NASDAQ:NGNE) Now Covered by Analysts at Lifesci Capital - Defense World
LifeSci Capital Initiates Coverage of Neurogene (NGNE) with Outperform Recommendation - Nasdaq
Analysts Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $42.50 - Defense World
Neurogene Inc. (NASDAQ:NGNE) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Aug Macro: Is Neurogene Inc stock risky to hold nowQuarterly Portfolio Report & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Risk Analysis: Can Neurogene Inc outperform under higher oil pricesTrade Ideas & Reliable Momentum Entry Alerts - baoquankhu1.vn
NGNE: NGN-401 shows durable, multi-domain gains in Rett syndrome, advancing toward commercialization - TradingView
Neurogene (NASDAQ:NGNE) Given “Buy” Rating at HC Wainwright - Defense World
Fund Flows: Does EXTR stock have upside surprise potentialMarket Movers & Fast Momentum Entry Tips - baoquankhu1.vn
Market Fear: Whats the analyst consensus on Neurogene Inc2025 Market Trends & Daily Volume Surge Signals - baoquankhu1.vn
Short Covering: Whats the analyst consensus on Neurogene IncJuly 2025 WrapUp & Weekly Stock Breakout Alerts - baoquankhu1.vn
HC Wainwright & Co. Reiterates Buy Rating for NGNE with $70 Pric - GuruFocus
Neurogene doses multiple patients in Rett syndrome gene therapy trial By Investing.com - Investing.com Nigeria
Neurogene outlines 2026 milestones for NGN-401 Rett therapy - The Globe and Mail
Neurogene Inc. Reports Q3 2025 Financial Results - MSN
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin - Investing.com Nigeria
Market Review: Whats the analyst consensus on Neurogene IncWeekly Trend Report & Weekly High Return Forecasts - baoquankhu1.vn
Neurogene doses multiple patients in Rett syndrome gene therapy trial - Investing.com
Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome - marketscreener.com
Neurogene Inc Announces Key Milestones for NGN-401 Gene Therapy - TradingView — Track All Markets
Boston Herald - FinancialContent
Neurogene Announces Positive Interim Data for NGN-401 - MSN
User | custercountychief.comNeurogene Inc.Common Stock (Nasdaq:NGNE) Stock Quote - FinancialContent
Is Neurogene Inc. stock a good choice for value investors2025 Volatility Report & Safe Capital Allocation Plans - Улправда
Is Neurogene Inc. stock gaining market shareJuly 2025 Macro Moves & Consistent Return Investment Signals - Улправда
What insider purchases suggest about Neurogene Inc. (UU8) stockJuly 2025 Retail & Safe Entry Point Identification - Улправда
Neurogene Inc. (NGNE) Stock Analysis: Uncovering a 208% Potential Upside in Biotechnology - DirectorsTalk Interviews
Will Neurogene Inc. (UU8) stock attract long term capital inflows2025 Winners & Losers & Community Verified Trade Alerts - Улправда
How Neurogene Inc. (UU8) stock correlates with oil marketsAI-Driven Market Analysis & Free Realize Exceptional Returns - Улправда
Will Neurogene Inc. stock benefit from upcoming earnings reportsStock Price Forecasts & Minimal Investment Big Returns - ulpravda.ru
What analysts say about Neurogene Inc UU8 stockStock Liquidity Analysis & Free Stock Predictions and Analysis - Early Times
Shanti Educational Initiatives Limited (539921) Announces Strategic ShiftEarly Times Newspaper Jammu - Early Times
Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference - New Castle News
Genetic medicines firm Neurogene opens its health conference talk online - Stock Titan
Neurogene Inc.Common Stock (NQ: NGNE - FinancialContent
Pullback Watch: Is Neurogene Inc stock a good choice for value investorsJuly 2025 Retail & AI Enhanced Trading Signals - moha.gov.vn
Breakout Move: How Applied Industrial Technologies Inc AT4 stock reacts to monetary easingTrend Reversal & Safe Swing Trade Setup Alerts - moha.gov.vn
Here's Why We're Not Too Worried About Neurogene's (NASDAQ:NGNE) Cash Burn Situation - Sahm
Craig-Hallum Initiates Coverage of Neurogene (NGNE) with Buy Recommendation - MSN
Neurogene Inc. (NASDAQ:NGNE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
What catalysts could drive Neurogene Inc. stock higherPortfolio Diversification Tips & Free Hedging Tactics for Volatile Markets - bollywoodhelpline.com
Sell Signal: Is Neurogene Inc stock gaining market shareJuly 2025 Sentiment & Low Risk High Reward Ideas - moha.gov.vn
Earnings Beat: Is Neurogene Inc stock a good choice for value investorsQuarterly Portfolio Summary & Verified Entry Point Signals - moha.gov.vn
Why Neurogene Inc. stock appeals to dividend seekersQuarterly Profit Summary & Weekly Breakout Watchlists - Улправда
Will Neurogene Inc. stock gain from lower inflationWeekly Trade Report & Daily Price Action Insights - DonanımHaber
1.24%
0.19%
자본화:
|
볼륨(24시간):